Characterization of three new enterococcal species, Enterococcus sp. nov. CDC PNS-E1, Enterococcus sp. nov. CDC

Maria da Glória S Carvalho1, Arnold G Steigerwalt, Roger E Morey

  • 1Division of Bacteria and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.

Insights

Three novel Enterococcus species were identified from human clinical samples. These new bacterial species were characterized using whole-cell protein profiles and DNA sequencing, with one strain exhibiting vancomycin resistance.

Area of Science:

  • Microbiology
  • Bacteriology
  • Clinical Microbiology

Background:

  • Accurate identification of catalase-negative, gram-positive cocci is crucial for clinical microbiology.
  • The Streptococcus Laboratory at CDC frequently encounters unusual or difficult-to-identify microorganisms.
  • Enterococcal species identification can be challenging, necessitating advanced characterization methods.

Purpose of the Study:

  • To precisely identify three unusual enterococcal strains isolated from human clinical sources.
  • To characterize novel taxa within the genus Enterococcus using a polyphasic approach.
  • To determine the taxonomic status of strains that did not conform to known enterococcal species.

Main Methods:

  • Systematic application of whole-cell protein profiles (WCPP) analysis.
  • DNA-DNA reassociation experiments for genetic relatedness assessment.
  • Conventional physiological tests and 16S ribosomal DNA (rDNA) sequencing.

Main Results:

  • Physiological testing was insufficient for confident species identification.
  • WCPP analysis revealed unique profiles distinct from known Enterococcus species.
  • 16S rDNA sequencing and DNA-DNA hybridization confirmed three distinct novel species within the Enterococcus genus, with <70% homology to known species.
  • One isolate (SS-1729) demonstrated vancomycin resistance, associated with the vanA gene.

Conclusions:

  • The three studied strains represent three new species of Enterococcus, isolated from human clinical specimens.
  • These findings expand the known diversity of the Enterococcus genus.
  • The identification of a vancomycin-resistant novel species highlights the importance of ongoing microbial surveillance.